Establishing a noninvasive image-based parameter capable of distinguishing tumor-specific from nonspecific probes is the key to accurately quantifying in vivo PD-L1 expression in a tumor population with heterogeneous PD-L1 levels. The gene discussed is CD274; the disease is neoplasm.